Search Press releases Keywords From To 3 Feb 2006 UCB Receives EMEA Positive Opinion and FDA Approvable Letter for Keppra® (levetiracetam) Intravenous Administration Read More 19 Jan 2006 UCB confirms good 2005 performance of Zyrtec in US and Xyzal Read More 17 Jan 2006 Lonza Acquires the Bioproducts Manufacturing Division of UCB Read More 12 Dec 2005 UCB confirms positive outlook for 2005 Read More 8 Dec 2005 Xyrem® is Launched in Germany for the Treatment of Cataplexy in Adults with Narcolepsy Read More 6 Dec 2005 New Data on the Use of Keppra® (levetiracetam) as Adjunctive Treatment in Idiopathic Generalised Epilepsy Patients with Primary Generalised Tonic-Clonic Seizures Read More Pagination First page Previous page Previous … Page 189 Page 190 Page 191 Page 192 Current page 193 Page 194 Page 195 Page 196 Page 197 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
